SPEAKERS:
Global Lifelong Burden of RSV – Louis Bont, M.D., Ph.D, Professor, University Medical Center Utrecht
Prefusion-F Stability and Vaccine Efficacy: Structure-Based Vaccines for RSV/HMPV/PIV – Peter Kwong, Ph.D, Richard J. Stock Professor, Biochemistry and Molecular Biophysics Columbia University
PIV5-vectored RSV Intranasal Vaccine (BLB201) is Safe and Immunogenic in Healthy Adults and Young Children, Hong Jin, Ph.D, Chief Scientific Officer, CynVac/Blue Lake Bio
RSVPreF Vaccine in Older Adults and At-Risk Adults Aged 18 – 59 Years – Kumar Ilangovan, MD, MSPH, MMCi, FACP, FAAP, Director, Vaccines Clinical Research & Global Clinical Lead, RSV Adult Vaccine Program, Pfizer Vaccine
Time:
US & Europe: 06:00 (PDT) | 09:00 (EDT) 14:00 (BST) | 15:00 (CEST)
South America: 10:00 (Argentina) | 07:00 (Mexico)
Africa: 14:00 (West Africa) | 15:00 (South Africa) | 16:00 (East Africa)
Asia: 18:30 (IST) | 21:00 (CST) | 22:00 (KST)
Australia: 21:00 (AWST) | 23:00 (AEST) | 23:00 (AEDT)